Özkan, Semra, and Deniz Gezer. “The Impact of Dapagliflozin on FIB-4 Index over 2 Years in Patients With Type 2 Diabetes Mellitus”. The European Research Journal, vol. 11, no. 4, July 2025, pp. 676-82, https://doi.org/10.18621/eurj.1631079.